In a world where pharmaceutical inputs can be disrupted by distant policies, port delays, or supply chain fragility, one question becomes urgent: how do we secure the medicines we rely on every day?
Today, we’re proud to publish:
“Localizing Active Pharmaceutical Ingredient Manufacturing in Saudi Arabia: A National Security Imperative.”
This document outlines a 15-year roadmap for upstream pharmaceutical independence, aligned with Vision 2030 and Saudi Arabia’s ambition to become a regional leader in healthcare resilience.
Highlights include:
* A phased, realistic strategy for building national API capability
* A call for institutional coordination, not just industrial investment
* A framework that links health security, strategic reserves, and sovereign manufacturing
This is not just a technical paper. It’s a call to design a system where medicine access is not left to chance—or to foreign policy.
Saudi Arabia has the timing, the tools, and the imperative.
Now comes the execution.
